Enveric Biosciences Files 8-K on Shareholder Votes & Financials
Ticker: ENVB · Form: 8-K · Filed: Jun 3, 2025 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting
TL;DR
Enveric Bio filed an 8-K covering shareholder votes and financials. Stay tuned for details.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on May 29, 2025, reporting on matters submitted to a vote of security holders and financial statements. The company, incorporated in Delaware, is based in Naples, Florida, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides updates on key corporate actions and financial reporting, which are crucial for investors to understand the company's governance and financial health.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating immediate operational or financial distress.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- 001-38286 (company) — SEC File Number
- 954484725 (company) — I.R.S. Employer Identification No.
- 4851 Tamiami Trail N, Suite 200 (company) — Principal Executive Offices Address
- Naples, FL (company) — Principal Executive Offices Location
- 20250529 (date) — Date of earliest event reported
- 20250603 (date) — Date of Report
FAQ
What specific matters were submitted to a vote of Enveric Biosciences' security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the primary business of Enveric Biosciences, Inc.?
Enveric Biosciences, Inc. operates in the Pharmaceutical Preparations sector, with SIC code 2834.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 29, 2025.
Where are Enveric Biosciences' principal executive offices located?
Enveric Biosciences' principal executive offices are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
What is the SEC file number for Enveric Biosciences?
The SEC file number for Enveric Biosciences is 001-38286.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding Enveric Biosciences, Inc. (ENVB).